COLLEGIUM PHARMACEUTICAL, INC
COLLNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for COLL. That does not mean none is planned.
Get an email about COLL's next catalysts
Track COLLEGIUM PHARMACEUTICAL (COLL) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
0 upcoming, 1 past
No catalysts found.
Market Overview
Stock performance and key metrics
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Oxycodone DETERx | Phase 3 | Chronic Low Back Pain | - | - |
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
What is in COLLEGIUM PHARMACEUTICAL, INC's drug pipeline?β
CatalystAlert tracks 1 drug candidate in COLLEGIUM PHARMACEUTICAL, INC's (COLL) pipeline across Phase 3. Its lead program is Oxycodone DETERx (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is COLLEGIUM PHARMACEUTICAL, INC's next FDA catalyst?β
CatalystAlert tracks every upcoming catalyst for COLLEGIUM PHARMACEUTICAL, INC (COLL) β PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings β each confidence-rated as confirmed, estimated or AI-detected.
How do I track COLL biotech catalysts?β
Add COLL to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow COLLEGIUM PHARMACEUTICAL, INC's live catalyst calendar, drug pipeline and clinical-trial timeline on this page β sourced from ClinicalTrials.gov, FDA and SEC filings.
